Riskpilot← Back to searchSign inGet full accessIFRIS AB
ABActiveOrg 5594723123Bågevägen 17Medical specialists activities · NACE 8622Est. 20241-4 employees
Revenue 2024
SEK 927K
EBITDA margin
54.8%
Equity ratio
53.7%
Financial strength
Net profit 2024
SEK 297K
| Revenue | SEK 927K | — |
| EBITDA | SEK 508K | — |
| Net profit | SEK 297K | — |
| Total assets | SEK 599K | — |
| Equity | SEK 322K | — |
| Employees | — | — |
Legal name
IFRIS AB
Org number
5594723123
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 februari 2024
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget kommer att erbjuda vetenskapliga stödtjänster inom medicinsk bildbehandling, inklusive (men inte begränsat till): - Ge vetenskaplig rådgivning om medicinska avbildningsmetoder - Utveckling av nya metoder för medicinsk bildtagning, efterbehandling och bildanalys. - Uppsättning av avbildningsprotokoll - Utbildning och undervisning i MR-fysik - Analys av bilder - Projektledning - Stöd till forskningsprojekt inom medicinsk bildbehandling - Stöd för marknadsföring och affärsverksamhet - Stöd för författande och granskning av vetenskapliga publikationer.
Address
Bågevägen 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 927 |
| Staff expenses | −53 |
| EBITDA | 508 |
| Depreciation & amort. | — |
| EBIT | 508 |
| Net financials | 0 |
| Profit before tax | 377 |
| Tax | −81 |
| Net profit | 297 |
| Item | 2024 |
|---|---|
| Total assets | 599 |
| Equity | 322 |
| Long-term debt | — |
| Short-term debt | 146 |
| Total debt | 146 |
EBITDA margin
54.8%
This company
15.8%
Market median
+247% vs market
20242024
Equity ratio
53.7%
This company
38.2%
Market median
+41% vs market
20242024
Return on equity
92.2%
This company
18.4%
Market median
+401% vs market
20242024
Net profit margin
32.0%
This company
8.1%
Market median
+295% vs market
20242024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
20242024
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20242024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-02-15 – 2024-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IFRIS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| David Fredrik Ljungberg | Deputy Board Member | 0 companies |
| Mats Helge Hellström | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Iris Rosina Sica Friedli | Board of Directors | 0 companies |